MDMA self‐administration in rats: acquisition, progressive ratio responding and serotonin transporter binding
Susan Schenk, Lincoln S. Hely, Barbara Lake, Evangelene Joy Kia Daniela, David Gittings, Deborah C. Mash
European Journal of Neuroscience November 16, 2007 DOI: 10.1111/j.1460-9568.2007.05932.x via OpenAlex
Summary
AI-generated from the abstractMDMA self-administration was studied in previously drug-naïve rats. Acquisition varied widely, with about 60% of rats learning to self-administer MDMA over 15 days, a lower rate and slower onset than for cocaine. Responding depended on dose, and breakpoints under a progressive ratio schedule increased with dose. Rats that self-administered MDMA showed lower densities of serotonin transporter sites (SERT) across brain regions, comparable to reductions from experimenter-administered MDMA. The findings indicate MDMA has high abuse liability and that long-term self-administration may cause lasting deficits in serotonin neurotransmission.
Study at a glance
| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Rats |
| Interventions | MDMA cocaine |
| Dose | 0.25 or 1.0 mg/kg/infusion |
| Duration | 15-day test period, daily 6-h sessions |
| Topics | MDMA Serotonin |
| Keywords | Self-administration Pharmacology Psychology Citalopram |
| Citations | 113 |
| Key finding | MDMA self-administration led to lower serotonin transporter densities across brain regions, comparable to experimenter-administered MDMA, supporting high abuse liability and lasting serotonin deficits. |
Abstract
Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) self‐administration has been shown in animals with extensive drug histories, but only a small number of studies have examined high rates of responding maintained by MDMA in previously drug‐naïve animals. In the present study, influence of dose (0.25 or 1.0 mg/kg/infusion) on the acquisition of MDMA self‐administration was measured during daily 6‐h sessions. Dose–effect data were obtained for MDMA (0.25–1.0 mg/kg/infusion) self‐administration under a progressive ratio (PR) schedule of reinforcement. The effect of experimenter‐ or self‐administered MDMA on [ 3 H] paroxetine binding in several brain regions was measured. Acquisition of MDMA self‐administration was highly variable and not different for 0.25 or 1.0 mg/kg/infusion progressed with approximately 60% of the rats acquiring reliable self‐administration during the 15‐day test period. The percentage of rats that acquired MDMA self‐administration was lower than the percentage of rats that acquired cocaine (0.5 mg/kg/infusion) self‐administration, and cocaine self‐administration was acquired with a shorter latency. Responding maintained by MDMA was dose dependent, and breakpoints under a PR schedule increased with dose. Radioligand binding and autoradiography demonstrated lower densities of serotonin transporter sites (SERT) in MDMA self‐administering rats as compared with controls across brain regions. The reduction in SERT densities was comparable in magnitude to rats treated with experimenter‐administered doses of MDMA. These data support the idea that MDMA is a drug with high abuse liability, and long‐term self‐administration may lead to long‐lasting deficits in serotonin neurotransmission.